Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2019 / Articles / Oct / A (Green) Dream Realized
Manufacture Technology and Equipment Technology & Manufacturing

A (Green) Dream Realized

Chemical reactors fueled by sunlight could push pharma towards a more sustainable future

By Maryam Mahdi 10/30/2019 0 min read Quick Read (pre 2022)

Share

Inspired by the way leaves, algae and some bacteria absorb light and focus energy, researchers at the University of Eindhoven in the Netherlands are harnessing solar energy to drive chemical reactions. The team, led by Timothy Noël, has developed a mini-reactor made of polymeric material that absorbs sunlight and converts it into a single color, which can then be directed towards reaction channels (similar to the veins of a leaf) (1). Raw chemical products are fed through the channels and the solar-derived energy facilitates the reaction necessary to create drug molecules.

Noël, an associate professor, who joined the University of Eindhoven in 2012, has been investigating the potential of conducting reactions using light. And though he and his research group initially used LEDs for this purpose, they soon began to explore how more natural sources of energy, such as sunlight, could be used to initiate chemical reactions. A prototype reactor was developed in 2016 and the team has since enhanced its design using PMMA plates and PFA capillaries, a solvent-resistant plastic, and has also incorporated stable dyes to help with the conversion of solar light.

As with any natural resource, sunlight is subject to natural variability, but the team has found a solution. “On a cloudy day, we have less light to work with than on a bright one. To combat this, we created a mini-feedback system that works to keep the conversion and yield the same level,” says Noël. By detecting changes in light intensity in real time, the system can adjust the flow rate of products passing through the reactor channels. 

To demonstrate the versatility of the device, the team has produced two drugs – artemisinin (an antimalarial) and ascaridole (an antiparasitic) – but, according to Noël, such reactors could be used to produce a wide variety of different therapeutic products.

“In 1912, an Italian photochemist, Giacomo Luigi Ciamician, described the world’s need to transition from fossil fuels to renewable energy. He also challenged the scientific community to imagine a chemical industry run on solar energy,” says Noël. “With our current understanding of environmental issues, it is clear that we must address this now. But analogous to the mass implementation of solar cells for electricity production, a political push and financial incentives will also be required for the implementation of solar energy in the chemical and pharmaceutical industries.”

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. T Noël, “Energy‐Efficient Solar Photochemistry with Luminescent Solar Concentrator Based Photomicroreactors”. Available at:https://bit.ly/2Zn03O7. Last accessed: September 24, 2019.

About the Author(s)

Maryam Mahdi

After finishing my degree, I envisioned a career in science communications. However, life took an unexpected turn and I ended up teaching abroad. Though the experience was amazing and I learned a great deal from it, I jumped at the opportunity to work for Texere. I'm excited to see where this new journey takes me!

More Articles by Maryam Mahdi

False

Advertisement

Recommended

False

Related Content

Battle of the Superbugs
Drug Discovery Technology and Equipment
Battle of the Superbugs

December 1, 2014

0 min read

Can phage endolysins revolutionize the way bacterial infections are treated – and prevent drug resistance?

All a Big Game?
Business Practice Technology and Equipment Trends & Forecasts
All a Big Game?

November 6, 2014

0 min read

“Welcome to Big Pharma, where you can make a fortune and still maintain a healthy conscience. Or can you?”

Beware the Dragonfly
Business Practice Technology and Equipment Trends & Forecasts
Beware the Dragonfly

November 6, 2014

0 min read

Mysterious cyber attackers are hitting pharma manufacturing systems

Future Proofing Track and Trace
Standards & Regulation Technology and Equipment
Future Proofing Track and Trace

November 6, 2014

0 min read

The US is finally introducing regulation on drug serialization and traceability, but gaps remain that could leave patients vulnerable.

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.